CervoMed(DE:DP8)
€1.250.00 (-0.79%)
DE:DP8
CervoMed financials statements
€1.25
At close:0.00 (-0.79%)
CervoMed (DP8) Ratios
3 Followers
CervoMed Ratios
DE:DP8's free cash flow for Q3 2026 was $-5.07M. For the 2026 fiscal year, DE:DP8's free cash flow was increased by $0.00 and operating cash flow was $-5.07M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.91 | 11.11 | 3.84 | 0.32 | 12.92 |
| Quick Ratio | 4.91 | 11.11 | 3.84 | 0.32 | 12.92 |
| Cash Ratio | 1.77 | 2.32 | 3.00 | 0.31 | 12.75 |
| Solvency Ratio | -5.79 | -4.20 | -0.84 | -0.44 | -8.20 |
| Operating Cash Flow Ratio | -5.04 | -4.26 | -2.87 | -0.20 | -4.95 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -0.21 | 0.00 |
| Net Current Asset Value | $ 18.22M | $ 39.20M | $ 7.37M | $ -9.00M | $ 34.90M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 2.99 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | -1.38 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 3.63 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.10 | 1.35 | -0.46 | 1.08 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | -0.47 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -5920.84 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 3.16 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 23.96 | 0.00 |
| Net Debt to EBITDA | 0.31 | 0.55 | 1.00 | -1.43 | 2.34 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 98.19% |
| EBT Per EBIT | 95.30% | 89.38% | 27.80% | 166.97% | 99.44% |
| Return on Assets (ROA) | -117.87% | -37.81% | -21.78% | -139.57% | -63.68% |
| Return on Equity (ROE) | -147.98% | -41.56% | -29.44% | 64.49% | -69.02% |
| Return on Capital Employed (ROCE) | -155.27% | -46.50% | -105.91% | 38.63% | -70.68% |
| Return on Invested Capital (ROIC) | -155.27% | -46.50% | -105.91% | -101.74% | -69.41% |
| Return on Tangible Assets | -117.87% | -37.81% | -21.78% | -139.57% | -63.68% |
| Earnings Yield | -37.75% | -86.24% | -10.70% | -147.56% | -79.60% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.59 | -2.05 | -2.80 | -4.97 | -11.14 |
| Free Cash Flow Per Share | -2.59 | -2.05 | -2.80 | -4.97 | -11.14 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | -2572759.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -2572759.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | -0.21 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -32.83% | -87.51% | -36.69% | -65.42% | -47.91% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.65 | -1.16 | -9.35 | -0.68 | -1.26 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 3.92 | 0.48 | 2.75 | -0.44 | 0.87 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.05 | -1.14 | -2.73 | -1.53 | -2.09 |
| Price-to-Operating Cash Flow Ratio | -3.05 | -1.14 | -2.73 | -1.53 | -2.09 |
| Price-to-Earnings Growth (PEG) Ratio | -0.06 | -0.01 | 0.10 | 0.02 | 0.07 |
| Enterprise Value Multiple | -2.34 | -0.61 | -1.60 | -2.11 | 0.44 |
| Enterprise Value | 63.19M | 9.89M | 12.51M | 12.25M | -7.04M |
| EV to EBITDA | -2.34 | -0.61 | -1.60 | -2.11 | 0.44 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -2.69 | -0.60 | -1.68 | -4.76 | 0.49 |
| EV to Operating Cash Flow | -2.69 | -0.60 | -1.68 | -4.76 | 0.49 |
| Tangible Book Value Per Share | 2.02 | 4.86 | 2.77 | -17.37 | 26.81 |
| Shareholders’ Equity Per Share | 2.02 | 4.86 | 2.77 | -17.37 | 26.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -2.98 | -2.02 | -0.82 | -11.20 | -18.51 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.98 |
| Interest Burden | 1.00 | 1.00 | 0.28 | 1.00 | 1.53 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.87 | 1.01 | 3.43 | 0.44 | 0.60 |
Currency in USD
